Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Continental Services Group, Inc.
FDA Inspection
•Continental Services Group, Inc.•May 21, 2024

Continental Services Group, Inc. – FDA Inspection, May 21, 2024

Record Details

This FDA Inspection record concerns Continental Services Group, Inc., with an inspection on May 21, 2024, issued by the Florida District Office, covering biologics.

Company
Continental Services Group, Inc.
Inspection Date
May 21, 2024
Product Type
Biologics
Office
Florida District Office
People
  • Fabian N. Chaparro-rodriguez (Issuing Officer)
  • Laura E. Garcia (Issuing Officer)
  • Nerming V. Briones (Investigator)
View Company Profile

ID · bace115f-0095-4b44-9371-fa77a52685a0

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1239104
FDA center
Biologics
Project area
Blood and Blood Products
Outcome
Form 483 issued

FDA Citations

11
  1. 21 CFR 600.10(b)Personnel capabilities
  2. 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
  3. 21 CFR 606.100(c)Thorough investigations
  4. 21 CFR 606.140(a)Establishment of spec., standards, and test procedures
  5. 21 CFR 606.140(c)Adequate identification and handling of test samples
  6. 21 CFR 606.160(a)(1)Person performing, test results, interpretation
  7. 21 CFR 606.160(b)Required records
  8. 21 CFR 606.40Clean & orderly
  9. 21 CFR 610.40(h)(2)(ii)Labeling of reactive units, units from deferred donors
  10. 21 CFR 610.41Donor Deferral

Showing 10 of 11 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Continental Services Group, Inc.

4
DateClassificationOfficeProject area
June 29, 2026Not classifiedFlorida District OfficeBlood and Blood Products
August 24, 2022NAICenter for Biologics Evaluation and ResearchVaccines and Allergenic Products
July 9, 2019VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
August 22, 2017VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
Other documents for Continental Services Group, Inc.
  • FDA Inspection 1326644 - 2026-06-29
  • FDA Inspection 1178110 - 2022-08-24
  • FDA Inspection 1096414 - 2019-07-09
  • FDA Inspection 1023396 - 2017-08-22

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Continental Services Group, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.